GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | April 23, 2025 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
6PZ8 | 6PZ8 | MERS S0 trimer in complex with variable domain of antibody G2 | |
6PZD | V9NZ28 | Crystal structure of the neuraminidase stabilization mutant Y169aH from A/Shanghai/2/2013 (H7N9) | |
6PZE | V9NZ28 | Crystal structure of human NA-45 Fab in complex with neuraminidase Y169aH mutant from A/Shanghai/2/2013 (H7N9) | |
6PZE | 6PZE | Crystal structure of human NA-45 Fab in complex with neuraminidase Y169aH mutant from A/Shanghai/2/2013 (H7N9) | |
6PZF | 6PZF | Crystal structure of human NA-63 Fab in complex with neuraminidase from A/Hunan/02650/2016(H7N9) | |
6PZW | S5MF06 | CryoEM derived model of NA-22 Fab in complex with N9 Shanghai2 | |
6PZW | 6PZW | CryoEM derived model of NA-22 Fab in complex with N9 Shanghai2 | |
6PZY | S5MF06 | CryoEM derived model of NA-73 Fab in complex with N9 Shanghai2 | |
6PZY | 6PZY | CryoEM derived model of NA-73 Fab in complex with N9 Shanghai2 | |
6PZZ | S5MF06 | CryoEM derived model of NA-80 Fab in complex with N9 Shanghai2 | |
6PZZ | 6PZZ | CryoEM derived model of NA-80 Fab in complex with N9 Shanghai2 | |
6Q04 | K0BRG7 | MERS-CoV S structure in complex with 5-N-acetyl neuraminic acid | |
6Q05 | K0BRG7 | MERS-CoV S structure in complex with sialyl-lewisX | |
6Q06 | K0BRG7 | MERS-CoV S structure in complex with 2,3-sialyl-N-acetyl-lactosamine | |
6Q07 | K0BRG7 | MERS-CoV S structure in complex with 2,6-sialyl-N-acetyl-lactosamine | |
6Q0H | B4UPF7 | Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1) | |
6Q0H | 6Q0H | Inferred intermediate I-7 (I-7-0) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1) | |
6Q0I | B4UPF7 | Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1) | |
6Q0I | 6Q0I | Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1) | |
6Q0L | B4UPF7 | Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1) | |
6Q0L | 6Q0L | Inferred intermediate I-7 (I-7-1) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/Beijing/262/95(H1N1) | |
6Q0O | 6Q0O | human antibody H2227 lineage 652 in complex with influenza hemagglutinin head domain of A/Solomon Islands/3/2006(H1N1) | |
6Q0S | P13843 | Crystal Structure of RSV strain B18537 Prefusion-stabilized glycoprotein F Variant DS-Cav1 | |
6Q18 | B4UPF7 | Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1) | |
6Q18 | 6Q18 | Human antibody H1244 in complex with the influenza hemagglutinin head domain of A/Beijing/262/95(H1N1) | |
6Q1N | B2R6A7 | Glucocerebrosidase in complex with pharmacological chaperone IMX8 | |
6Q1P | B2R6A7 | Glucocerebrosidase in complex with pharmacological chaperone norIMX8 | |
6Q1Z | 6Q1Z | Crystal structure of human 1G04 Fab in complex with influenza virus neuraminidase from A/Hunan/02650/2016 (H7N9) | |
6Q20 | C7RWN0 | Crystal structure of human 1E01 Fab in complex with influenza virus neuraminidase from A/Japan/305/1957 (H2N2) | |
6Q20 | 6Q20 | Crystal structure of human 1E01 Fab in complex with influenza virus neuraminidase from A/Japan/305/1957 (H2N2) | |
6Q23 | C5MQL2 | Crystal structure of human 1G01 Fab in complex with influenza virus neuraminidase from A/California/04/2009 (H1N1) | |
6Q23 | 6Q23 | Crystal structure of human 1G01 Fab in complex with influenza virus neuraminidase from A/California/04/2009 (H1N1) | |
6Q27 | A0A266CX40 | N-acetylmannosamine kinase with N-acetylmannosamine from Staphylococcus aureus | |
6Q28 | A0A266CX40 | Metal ROK rebel: Characterisation of N-acetylmannosamine kinase from the pathogen Staphylococcus aureus | |
6Q2J | Q99988 | Cryo-EM structure of extracellular dimeric complex of RET/GFRAL/GDF15 | |
6Q2J | Q6UXV0 | Cryo-EM structure of extracellular dimeric complex of RET/GFRAL/GDF15 | |
6Q2J | P07949 | Cryo-EM structure of extracellular dimeric complex of RET/GFRAL/GDF15 | |
6Q2O | Q99748 | Cryo-EM structure of RET/GFRa2/NRTN extracellular complex. The 3D refinement was applied with C2 symmetry. | |
6Q2O | O00451 | Cryo-EM structure of RET/GFRa2/NRTN extracellular complex. The 3D refinement was applied with C2 symmetry. | |
6Q2O | P07949 | Cryo-EM structure of RET/GFRa2/NRTN extracellular complex. The 3D refinement was applied with C2 symmetry. | |
6Q2R | Q99748 | Cryo-EM structure of RET/GFRa2/NRTN extracellular complex in the tetrameric form | |
6Q2R | O00451 | Cryo-EM structure of RET/GFRa2/NRTN extracellular complex in the tetrameric form | |
6Q2R | P07949 | Cryo-EM structure of RET/GFRa2/NRTN extracellular complex in the tetrameric form | |
6Q2S | Q5T4W7 | Cryo-EM structure of RET/GFRa3/ARTN extracellular complex. The 3D refinement was applied with C2 symmetry. | |
6Q2S | Q12306 | Cryo-EM structure of RET/GFRa3/ARTN extracellular complex. The 3D refinement was applied with C2 symmetry. | |
6Q2S | O60609 | Cryo-EM structure of RET/GFRa3/ARTN extracellular complex. The 3D refinement was applied with C2 symmetry. | |
6Q2S | P07949 | Cryo-EM structure of RET/GFRa3/ARTN extracellular complex. The 3D refinement was applied with C2 symmetry. | |
6Q3R | P48842 | ASPERGILLUS ACULEATUS GALACTANASE | |
6Q3W | P51570 | Structure of human galactokinase 1 bound with Ethyl 1-(2-pyrazinyl)-4-piperidinecarboxylate | |
6Q3X | P51570 | Structure of human galactokinase in complex with galactose and 2'-(benzo[d]oxazol-2-ylamino)-7',8'-dihydro-1'H-spiro[cyclohexane-1,4'-quinazolin]-5'(6'H)-one |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025